Rate My Professor Hendra Gunosewoyo

In 2013, Gunosewoyo joined the School of Pharmacy and Biomedical Sciences at Curtin University as a Research Fellow, advancing to Lecturer in 2015 and Senior Lecturer in 2019. His research specializes in medicinal chemistry, with a focus on designing and synthesizing novel inhibitors for infectious diseases, particularly tuberculosis. He targets mycobacterial kinases and phosphatases such as PknG, MPtpA, MPtpB, and SapM to enhance host immune responses against Mycobacterium tuberculosis. Additional interests include neurodegeneration, neuroinflammation, cannabinoids, and glycogen synthase kinase-3β inhibitors. He is involved with the Curtin Medical Research Institute in inflammation, infectious disease, and wounds research. Notable publications include 'Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis' (Journal of Medicinal Chemistry, 2018), 'Indoleamides are active against drug-resistant Mycobacterium tuberculosis' (Nature Communications, 2013), 'Tuberculosis: Pathogenesis, Current Treatment Regimens and New Drug Candidates' (Pharmaceutics, 2023), and 'Combating Tuberculosis via Restoring the Host Immune Capacity by Targeting M. tb Kinases and Phosphatases' (International Journal of Molecular Sciences, 2024). Gunosewoyo supervises Honours, Masters, and PhD students and coordinates units in bioscience practice.